Blossom

Helping psychedelics become approved medicines

Blossom makes information about the potential of psychedelics available to all stakeholders to help speed up the psychedelic transition from trials to practice.

We are perpetually answering the question: How do psychedelics become medicines?

Timely & Relevant

Every day we make available the insights coming from psychedelic research and the companies implementing these insights. Through our own newsletter (The Bloom) and our partners (e.g. Lucid News), we spread this information.

We believe that providing timely and relevant information will help research stay updated with the field, let companies find discoveries quicker, and regulators shed outdated beliefs.

Insightful & Evergreen

We back up these insights by providing an insightful and evergreen database of all things related to psychedelics as medicines. We make the troves of hidden data visible through detailed and easily searchable information on psychedelic papers, companies, key people, news, events, and more databases.

Next to the individual databases, we bring together disparate pieces of the psychedelic landscape in detailed reports. Both resources help laypeople get a quick gain overview, help researchers see what is happening in the rest of the field, and help regulators identify where the field stands.